Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Sequential chemoimmunotherapy of experimental visceral leishmaniasis using a single low dose of liposomal amphotericin B and a novel DNA vaccine candidate.
SEIFERT, K; Juhls, C; Salguero, FJ; CROFT, SL;
2015
Antimicrobial agents and chemotherapy, (2015).59 9 10.1128/AAC.00273-15.
Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status.
RHODES, SJ; KNIGHT, GM; FIELDING, K; Scriba, TJ; Pathan, AA; McShane, H; FLETCHER, H; WHITE, RG;
2015
Tuberculosis (Edinburgh, Scotland), (2015).96, 10.1016/j.tube.2015.10.002.
10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) induces memory B cell responses in healthy Kenyan toddlers.
Muema, DM; Nduati, EW; Uyoga, M; Bashraheil, M; SCOTT, JA G; Hammitt, LL; Urban, BC;
2015
Clinical and experimental immunology, (2015).181 2 10.1111/cei.12637.
Cost-effectiveness of Haemophilus influenzae type b vaccine in Vietnam.
Le, P; GRIFFITHS, UK; Anh, DD; Franzini, L; Chan, W; Swint, JM;
2015
Vaccine, (2015).33 36 10.1016/j.vaccine.2015.05.050.
Implementation of the malaria candidate vaccine RTS,S/AS01.
GREENWOOD, B; Doumbo, OK;
2015
Lancet, (2015).387 10016 10.1016/S0140-6736(15)00807-7.
Differential transcriptomic and metabolic profiles of M. africanum- and M. tuberculosis-infected patients after, but not before, drug treatment.
TIENTCHEU, LD; Maertzdorf, J; Weiner, J; ADETIFA, IM; Mollenkopf, H-J; SUTHERLAND, JS; Donkor, S; KAMPMANN, B; Kaufmann, SH E; DOCKRELL, HM; Ota, MO;
2015
Genes and immunity, (2015).16 5 10.1038/gene.2015.21.
Thirty years of vaccination in Vietnam: Impact and cost-effectiveness of the national Expanded Programme on Immunization.
JIT, M; Dang, TT H; Friberg, I; Hoang, VM; Pham Huy, TK; Walker, N; Nguyen, VC; Tran, ND; Toda, K; Hutubessy, R; Fox, K; Nguyen, TH;
2015
Vaccine, (2015).33 Sup Suppl 10.1016/j.vaccine.2014.12.017.
Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models.
Penny, MA; Verity, R; Bever, CA; Sauboin, C; Galactionova, K; FLASCHE, S; White, MT; Wenger, EA; Van de Velde, N; Pemberton-Ross, P; Griffin, JT; Smith, TA; Eckhoff, PA; Muhib, F; JIT, M; Ghani, AC;
2015
Lancet, (2015).387 10016 10.1016/S0140-6736(15)00725-4.
Consensus on the development of vaccines against naturally acquired melioidosis.
Limmathurotsakul, D; Funnell, SG P; Torres, AG; Morici, LA; Brett, PJ; Dunachie, S; Atkins, T; Altmann, DM; BANCROFT, G; PEACOCK, SJ; Steering Group on Melioidosis Vaccine Development,;
2015
Emerging infectious diseases, (2015).21 6 10.3201/eid2106.141480.
Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience.
Jauregui, B; Garcia, AG F; Bess Janusz, C; Blau, J; Munier, A; Atherly, D; Mvundura, M; Hajjeh, R; Lopman, B; CLARK, AD; BAXTER, L; Hutubessy, R; De Quadros, C; Andrus, JK;
2015
Vaccine, (2015).33 Sup 0 1 10.1016/j.vaccine.2014.10.090.